Stone X Group Inc. Vertex Pharmaceuticals Inc Transaction History

Stone X Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $8,762 - $9,776	32 Added 3.95%	843 $244,000
Q2 2022 Jul 27, 2022	BUY	$234.96 - $292.55 $190,552 - $237,258	811 New	811 $229,000
Q3 2017 Nov 13, 2017	SELL	$148.13 - $162.24 $864,931 - $947,319	-5,839 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	5,839	5,839 $752,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.